Search results from the "OB_Rx" table for query on "021086."


Active Ingredient: OLANZAPINE
Dosage Form;Route: TABLET, ORALLY DISINTEGRATING; ORAL
Proprietary Name: ZYPREXA ZYDIS
Applicant: LILLY
Strength: 5MG
Application Number: 021086
Product Number: 001
Approval Date: Apr 6, 2000
Reference Listed Drug Yes
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View
Active Ingredient: OLANZAPINE
Dosage Form;Route: TABLET, ORALLY DISINTEGRATING; ORAL
Proprietary Name: ZYPREXA ZYDIS
Applicant: LILLY
Strength: 10MG
Application Number: 021086
Product Number: 002
Approval Date: Apr 6, 2000
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View
Active Ingredient: OLANZAPINE
Dosage Form;Route: TABLET, ORALLY DISINTEGRATING; ORAL
Proprietary Name: ZYPREXA ZYDIS
Applicant: LILLY
Strength: 15MG
Application Number: 021086
Product Number: 003
Approval Date: Apr 6, 2000
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View
Active Ingredient: OLANZAPINE
Dosage Form;Route: TABLET, ORALLY DISINTEGRATING; ORAL
Proprietary Name: ZYPREXA ZYDIS
Applicant: LILLY
Strength: 20MG
Application Number: 021086
Product Number: 004
Approval Date: Apr 6, 2000
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:
    Orange Book Data - Monthly
    Generic Drug Product Information & Patent Information - Daily
    Orange Book Data Updated Through October, 2009
    Patent and Generic Drug Product Data Last Updated: November 20, 2009